Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Virchows Archiv : an International Journal of Pathology|April 14, 2021
Granulomatous mastitis caused by Rickettsia speciesAnnette Bauer, Syster Hofmeyer, Maria Gere, et al.
American Journal of Obstetrics and Gynecology|January 12, 2010
Tissue tumor marker expression in smokers, including serum cotinine concentrations, in women with cervical intraepithelial neoplasia or normal squamous cervical epitheliumRaghad Samir, Anna Asplund, Tibor Tot, et al.
Oncology Letters|October 29, 2021
Integrative meta-analysis of gene expression profiles identifies FEN1 and ENDOU as potential diagnostic biomarkers for cervical squamous cell carcinomaVladimir Basic, Boxi Zhang, Jakob Domert, et al.
Frontiers in Oncology|July 24, 2023
HER2-low metastases of HER2-negative primary tumors: a single institution analysis of intertumoral and internodal heterogeneity in node-positive breast cancerUlrika Pellas, Annette Bauer, Ilija Vladimir Baroš, et al.
Anticancer Research|January 4, 2012
Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancerDavid Lindquist, Andreas Ahrlund-Richter, Miklós Tarján, et al.
Anticancer Research|June 29, 2007
Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressionsAnnika K Lindström, Ulf Stendahl, Tibor Tot, et al.
European Radiology|August 5, 2003
Invasive breast cancer: correlation of dynamic MR features with prognostic factorsBotond K Szabó, Peter Aspelin, Maria Kristoffersen Wiberg, et al.
Virchows Archiv : an International Journal of Pathology|July 22, 2009
The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potentialTibor Tot, Gyula Pekár, Syster Hofmeyer, et al.
International Journal of Breast Cancer|October 26, 2012
Comparison of the subgross distribution of the lesions in invasive ductal and lobular carcinomas of the breast: a large-format histology studySyster Hofmeyer, Gyula Pekár, Mária Gere, et al.
Histopathology|August 17, 2018
Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefitsGyula Pekar, Ionna Kasselaki, Agnes Pekar-Lukacs, et al.
Pageof 8